Latest News

OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

Kaplan Fox Alerts Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) – Deadline is November 3, 2026

Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway

Greenland Mines Doubles AnorTech Stake to 19.9%; Extends Critical-Minerals Platform to Smelter-Grade Alumina, Lunar Construction Materials

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

Cyabra Awarded Positions on FBI Multi-Award IDIQ Contract for Specialized Open-Source Intelligence (OSINT) Tools

AMTD's TGE in Negotiations to Acquire a second New York Hotel

U.S. Based Rare Earth Company Winner Water to Join SPD and Mobix Labs (Nasdaq: MOBX) National Security Matters Initiative

Vertiv Appoints Michael Resha to Lead Global Manufacturing and Operational Excellence